Selected research
Industry Research
Ondansetron Hydrochloride Tablets Industry Research Report 2026
Market perspective
The global Ondansetron Hydrochloride Tablets market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Ondansetron Hydrochloride Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Ondansetron Hydrochloride Tablets is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Ondansetron Hydrochloride Tablets is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Ondansetron Hydrochloride Tablets include GSK, Aden Healthcare, Aurobindo Pharma, Henry Schein, Morningside Pharmaceuticals, Mylan, Novartis, Takeda and Teva, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Ondansetron Hydrochloride Tablets market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Ondansetron Hydrochloride Tablets Market by Company
GSK
Aden Healthcare
Aurobindo Pharma
Henry Schein
Morningside Pharmaceuticals
Mylan
Novartis
Takeda
Teva
PKU Healthcare
Ningbo Tianheng Pharmaceutical
Qilu Pharmaceutical
Shanghai Pharmaceuticals
SJZ No.4 Pharmaceutical
Ondansetron Hydrochloride Tablets Segment by Type
Ordinary Tablets
Oraliy Disintegrating Tablets
Ondansetron Hydrochloride Tablets Segment by Application
Pharmacy
Hospital and Clinic
Other
Ondansetron Hydrochloride Tablets Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Ondansetron Hydrochloride Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Ondansetron Hydrochloride Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Ondansetron Hydrochloride Tablets.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Ondansetron Hydrochloride Tablets manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Ondansetron Hydrochloride Tablets by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Ondansetron Hydrochloride Tablets in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Ordinary Tablets
- Oraliy Disintegrating Tablets
Applications
- Pharmacy
- Hospital and Clinic
- Other
Companies covered
- GSK
- Aden Healthcare
- Aurobindo Pharma
- Henry Schein
- Morningside Pharmaceuticals
- Mylan
- Novartis
- Takeda
- Teva
- PKU Healthcare
- Ningbo Tianheng Pharmaceutical
- Qilu Pharmaceutical
- Shanghai Pharmaceuticals
- SJZ No.4 Pharmaceutical
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Ondansetron Hydrochloride Tablets Market Size (2021-2032)
- 2.2.2 Global Ondansetron Hydrochloride Tablets Sales (2021-2032)
- 2.2.3 Global Ondansetron Hydrochloride Tablets Market Average Price (2021-2032)
- 2.3 Ondansetron Hydrochloride Tablets by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Ordinary Tablets
- 2.3.3 Oraliy Disintegrating Tablets
- 2.4 Ondansetron Hydrochloride Tablets by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Pharmacy
- 2.4.3 Hospital and Clinic
- 2.4.4 Other
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Ondansetron Hydrochloride Tablets Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Ondansetron Hydrochloride Tablets Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Ondansetron Hydrochloride Tablets Revenue of Manufacturers (2021-2026)
- 3.4 Global Ondansetron Hydrochloride Tablets Average Price by Manufacturers (2021-2026)
- 3.5 Global Ondansetron Hydrochloride Tablets Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Ondansetron Hydrochloride Tablets, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Ondansetron Hydrochloride Tablets, Product Type & Application
- 3.8 Global Manufacturers of Ondansetron Hydrochloride Tablets, Established Date
- 3.9 Global Ondansetron Hydrochloride Tablets Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 GSK
- 4.1.1 GSK Company Information
- 4.1.2 GSK Business Overview
- 4.1.3 GSK Ondansetron Hydrochloride Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 GSK Ondansetron Hydrochloride Tablets Product Portfolio
- 4.1.5 GSK Recent Developments
- 4.2 Aden Healthcare
- 4.2.1 Aden Healthcare Company Information
- 4.2.2 Aden Healthcare Business Overview
- 4.2.3 Aden Healthcare Ondansetron Hydrochloride Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Aden Healthcare Ondansetron Hydrochloride Tablets Product Portfolio
- 4.2.5 Aden Healthcare Recent Developments
- 4.3 Aurobindo Pharma
- 4.3.1 Aurobindo Pharma Company Information
- 4.3.2 Aurobindo Pharma Business Overview
- 4.3.3 Aurobindo Pharma Ondansetron Hydrochloride Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Aurobindo Pharma Ondansetron Hydrochloride Tablets Product Portfolio
- 4.3.5 Aurobindo Pharma Recent Developments
- 4.4 Henry Schein
- 4.4.1 Henry Schein Company Information
- 4.4.2 Henry Schein Business Overview
- 4.4.3 Henry Schein Ondansetron Hydrochloride Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Henry Schein Ondansetron Hydrochloride Tablets Product Portfolio
- 4.4.5 Henry Schein Recent Developments
- 4.5 Morningside Pharmaceuticals
- 4.5.1 Morningside Pharmaceuticals Company Information
- 4.5.2 Morningside Pharmaceuticals Business Overview
- 4.5.3 Morningside Pharmaceuticals Ondansetron Hydrochloride Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Morningside Pharmaceuticals Ondansetron Hydrochloride Tablets Product Portfolio
- 4.5.5 Morningside Pharmaceuticals Recent Developments
- 4.6 Mylan
- 4.6.1 Mylan Company Information
- 4.6.2 Mylan Business Overview
- 4.6.3 Mylan Ondansetron Hydrochloride Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Mylan Ondansetron Hydrochloride Tablets Product Portfolio
- 4.6.5 Mylan Recent Developments
- 4.7 Novartis
- 4.7.1 Novartis Company Information
- 4.7.2 Novartis Business Overview
- 4.7.3 Novartis Ondansetron Hydrochloride Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Novartis Ondansetron Hydrochloride Tablets Product Portfolio
- 4.7.5 Novartis Recent Developments
- 4.8 Takeda
- 4.8.1 Takeda Company Information
- 4.8.2 Takeda Business Overview
- 4.8.3 Takeda Ondansetron Hydrochloride Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Takeda Ondansetron Hydrochloride Tablets Product Portfolio
- 4.8.5 Takeda Recent Developments
- 4.9 Teva
- 4.9.1 Teva Company Information
- 4.9.2 Teva Business Overview
- 4.9.3 Teva Ondansetron Hydrochloride Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Teva Ondansetron Hydrochloride Tablets Product Portfolio
- 4.9.5 Teva Recent Developments
- 4.10 PKU Healthcare
- 4.10.1 PKU Healthcare Company Information
- 4.10.2 PKU Healthcare Business Overview
- 4.10.3 PKU Healthcare Ondansetron Hydrochloride Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 PKU Healthcare Ondansetron Hydrochloride Tablets Product Portfolio
- 4.10.5 PKU Healthcare Recent Developments
- 4.11 Ningbo Tianheng Pharmaceutical
- 4.11.1 Ningbo Tianheng Pharmaceutical Company Information
- 4.11.2 Ningbo Tianheng Pharmaceutical Business Overview
- 4.11.3 Ningbo Tianheng Pharmaceutical Ondansetron Hydrochloride Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Ningbo Tianheng Pharmaceutical Ondansetron Hydrochloride Tablets Product Portfolio
- 4.11.5 Ningbo Tianheng Pharmaceutical Recent Developments
- 4.12 Qilu Pharmaceutical
- 4.12.1 Qilu Pharmaceutical Company Information
- 4.12.2 Qilu Pharmaceutical Business Overview
- 4.12.3 Qilu Pharmaceutical Ondansetron Hydrochloride Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Qilu Pharmaceutical Ondansetron Hydrochloride Tablets Product Portfolio
- 4.12.5 Qilu Pharmaceutical Recent Developments
- 4.13 Shanghai Pharmaceuticals
- 4.13.1 Shanghai Pharmaceuticals Company Information
- 4.13.2 Shanghai Pharmaceuticals Business Overview
- 4.13.3 Shanghai Pharmaceuticals Ondansetron Hydrochloride Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Shanghai Pharmaceuticals Ondansetron Hydrochloride Tablets Product Portfolio
- 4.13.5 Shanghai Pharmaceuticals Recent Developments
- 4.14 SJZ No.4 Pharmaceutical
- 4.14.1 SJZ No.4 Pharmaceutical Company Information
- 4.14.2 SJZ No.4 Pharmaceutical Business Overview
- 4.14.3 SJZ No.4 Pharmaceutical Ondansetron Hydrochloride Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 SJZ No.4 Pharmaceutical Ondansetron Hydrochloride Tablets Product Portfolio
- 4.14.5 SJZ No.4 Pharmaceutical Recent Developments
5 Global Ondansetron Hydrochloride Tablets Market Scenario by Region
- 5.1 Global Ondansetron Hydrochloride Tablets Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Ondansetron Hydrochloride Tablets Sales by Region: 2021-2032
- 5.2.1 Global Ondansetron Hydrochloride Tablets Sales by Region: 2021-2026
- 5.2.2 Global Ondansetron Hydrochloride Tablets Sales by Region: 2027-2032
- 5.3 Global Ondansetron Hydrochloride Tablets Revenue by Region: 2021-2032
- 5.3.1 Global Ondansetron Hydrochloride Tablets Revenue by Region: 2021-2026
- 5.3.2 Global Ondansetron Hydrochloride Tablets Revenue by Region: 2027-2032
- 5.4 North America Ondansetron Hydrochloride Tablets Market Facts & Figures by Country
- 5.4.1 North America Ondansetron Hydrochloride Tablets Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Ondansetron Hydrochloride Tablets Sales by Country (2021-2032)
- 5.4.3 North America Ondansetron Hydrochloride Tablets Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Ondansetron Hydrochloride Tablets Market Facts & Figures by Country
- 5.5.1 Europe Ondansetron Hydrochloride Tablets Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Ondansetron Hydrochloride Tablets Sales by Country (2021-2032)
- 5.5.3 Europe Ondansetron Hydrochloride Tablets Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Ondansetron Hydrochloride Tablets Market Facts & Figures by Country
- 5.6.1 Asia Pacific Ondansetron Hydrochloride Tablets Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Ondansetron Hydrochloride Tablets Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Ondansetron Hydrochloride Tablets Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Ondansetron Hydrochloride Tablets Market Facts & Figures by Country
- 5.7.1 South America Ondansetron Hydrochloride Tablets Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Ondansetron Hydrochloride Tablets Sales by Country (2021-2032)
- 5.7.3 South America Ondansetron Hydrochloride Tablets Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.7.7 Colombia
- 5.8 Middle East and Africa Ondansetron Hydrochloride Tablets Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Ondansetron Hydrochloride Tablets Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Ondansetron Hydrochloride Tablets Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Ondansetron Hydrochloride Tablets Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Ondansetron Hydrochloride Tablets Sales by Type (2021-2032)
- 6.1.1 Global Ondansetron Hydrochloride Tablets Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Ondansetron Hydrochloride Tablets Sales Market Share by Type (2021-2032)
- 6.2 Global Ondansetron Hydrochloride Tablets Revenue by Type (2021-2032)
- 6.2.1 Global Ondansetron Hydrochloride Tablets Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Ondansetron Hydrochloride Tablets Revenue Market Share by Type (2021-2032)
- 6.3 Global Ondansetron Hydrochloride Tablets Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Ondansetron Hydrochloride Tablets Sales by Application (2021-2032)
- 7.1.1 Global Ondansetron Hydrochloride Tablets Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Ondansetron Hydrochloride Tablets Sales Market Share by Application (2021-2032)
- 7.2 Global Ondansetron Hydrochloride Tablets Revenue by Application (2021-2032)
- 7.2.1 Global Ondansetron Hydrochloride Tablets Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Ondansetron Hydrochloride Tablets Revenue Market Share by Application (2021-2032)
- 7.3 Global Ondansetron Hydrochloride Tablets Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Ondansetron Hydrochloride Tablets Value Chain Analysis
- 8.1.1 Ondansetron Hydrochloride Tablets Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Ondansetron Hydrochloride Tablets Production Mode & Process
- 8.2 Ondansetron Hydrochloride Tablets Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Ondansetron Hydrochloride Tablets Distributors
- 8.2.3 Ondansetron Hydrochloride Tablets Customers
9 Global Ondansetron Hydrochloride Tablets Analyzing Market Dynamics
- 9.1 Ondansetron Hydrochloride Tablets Industry Trends
- 9.2 Ondansetron Hydrochloride Tablets Industry Drivers
- 9.3 Ondansetron Hydrochloride Tablets Industry Opportunities and Challenges
- 9.4 Ondansetron Hydrochloride Tablets Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst